Octreotide - 63323-376-01 - (OCTREOTIDE ACETATE)

Alphabetical Index


Drug Information of Octreotide

Product NDC: 63323-376
Proprietary Name: Octreotide
Non Proprietary Name: OCTREOTIDE ACETATE
Active Ingredient(s): 100    ug/mL & nbsp;   OCTREOTIDE ACETATE
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Octreotide

Product NDC: 63323-376
Labeler Name: Fresenius Kabi USA, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077457
Marketing Category: ANDA
Start Marketing Date: 20060314

Package Information of Octreotide

Package NDC: 63323-376-01
Package Description: 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-376-01) > 1 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Octreotide

NDC Code 63323-376-01
Proprietary Name Octreotide
Package Description 10 VIAL, SINGLE-DOSE in 1 TRAY (63323-376-01) > 1 mL in 1 VIAL, SINGLE-DOSE
Product NDC 63323-376
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name OCTREOTIDE ACETATE
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20060314
Marketing Category Name ANDA
Labeler Name Fresenius Kabi USA, LLC
Substance Name OCTREOTIDE ACETATE
Strength Number 100
Strength Unit ug/mL
Pharmaceutical Classes Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA]

Complete Information of Octreotide


General Information